Neural stem cells in the adult subventricular zone oxidize fatty acids to produce energy and support neurogenic activity. by Stoll EA et al.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This work is licensed under a Creative Commons Attribution 4.0 International License 
 
 
Newcastle University ePrints - eprint.ncl.ac.uk 
 
Stoll EA, Makin R, Sweet IR, Trevelyan AJ, Miwa S, Horner PJ, Turnbull DM. 
Neural stem cells in the adult subventricular zone oxidize fatty acids to 
produce energy and support neurogenic activity. Stem Cells 2015, 33(7), 
2306-2319. 
 
 
Copyright: 
© 2015 The Authors. STEM CELLS published by Wiley Periodicals, Inc. on behalf of AlphaMed Press 
This is an open access article under the terms of the Creative Commons Attribution License, which 
permits use, distribution and reproduction in any medium, provided the original work is properly cited. 
DOI link to article: 
http://dx.doi.org/10.1002/stem.2042  
Date deposited:   
07/09/2015 
  
Neural Stem Cells in the Adult Subventricular Zone
Oxidize Fatty Acids to Produce Energy and Support
Neurogenic Activity
ELIZABETH A. STOLL,a,b,c,d REBECCA MAKIN,e IAN R. SWEET,f ANDREW J. TREVELYAN,d
SATOMI MIWA,c PHILIP J. HORNER,g DOUGLASS M. TURNBULLa,b,c,d
Key Words. Neural stem cell • Progenitor • Neurogenesis • Fatty acid oxidation • Proliferation •
Differentiation
ABSTRACT
Neural activity is tightly coupled to energy consumption, particularly sugars such as glucose.
However, we find that, unlike mature neurons and astrocytes, neural stem/progenitor cells
(NSPCs) do not require glucose to sustain aerobic respiration. NSPCs within the adult subven-
tricular zone (SVZ) express enzymes required for fatty acid oxidation and show sustained
increases in oxygen consumption upon treatment with a polyunsaturated fatty acid. NSPCs also
demonstrate sustained decreases in oxygen consumption upon treatment with etomoxir, an
inhibitor of fatty acid oxidation. In addition, etomoxir decreases the proliferation of SVZ NSPCs
without affecting cellular survival. Finally, higher levels of neurogenesis can be achieved in aged
mice by ectopically expressing proliferator-activated receptor gamma coactivator 1 alpha
(PGC1a), a factor that increases cellular aerobic capacity by promoting mitochondrial biogenesis
and metabolic gene transcription. Regulation of metabolic fuel availability could prove a power-
ful tool in promoting or limiting cellular proliferation in the central nervous system. STEM CELLS
2015;33:2306—2319
SIGNIFICANCE STATEMENT
Most cell types in the adult brain rely on sugars such as glucose to produce energy. In this
study, we find that neural stem cells in the adult brain use fatty acids to power respiratory
activity and cell division. The identification of metabolic substrates required by the adult neural
stem cell is imperative to understanding the process of regeneration. Regulation of metabolic
fuel availability may even prove a powerful tool in promoting or limiting cellular proliferation
in the central nervous system.
INTRODUCTION
Neural stem/progenitor cells (NSPCs), which
retain the capacity to produce new neurons
and glia in the adult mammalian brain, reside
in the subventricular zone (SVZ) of the lateral
ventricle and the subgranular zone of hippo-
campal dentate gyrus (DG) [1, 2]. While newly
born cells in the inner molecular cell layer of
DG migrate locally, cells from SVZ migrate long
distances along the rostral migratory stream to
populate the olfactory bulb (OB) with new
GABAergic interneurons including dopaminer-
gic neurons [3]. The control of neurogenesis in
the adult brain is notoriously complex, and
depends upon factors in both the extracellular
environment and limitations within the cellular
machinery [4]. As NSPCs reside in a
“neurogenic niche” fortified by blood vessels
and astrocytes [5], these cells have direct
access to contents in the bloodstream, includ-
ing substrates to fuel energy metabolism. In
this study, we investigated the substrates
required by adult mammalian neural stem cells
to maintain their metabolic and neurogenic
activity.
Catabolism, the production of energy in
the form of ATP, is necessary to sustain cellular
activity. The adult brain primarily depends
upon the oxidation of carbohydrates such as
glucose to fuel energy production. Although
the brain comprises about 2% of body weight,
this organ accounts for approximately 25% of
organismal glucose consumption and 20% of
oxygen consumption. Neuronal activity is
indeed tightly coupled to glucose uptake [6].
However, intriguingly, neurons and astrocytes
have recently been shown to compartmental-
ize metabolic processes [7, 8]. Glutamate
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TISSUE-SPECIFIC STEM CELLS
released by neurons during synaptic transmission triggers astro-
cytic uptake of blood-borne glucose. Astrocytes then undergo
glycolysis, metabolizing glucose into pyruvate then releasing
excess end products in the form of lactate into the extracellular
space via the monocarboxylate transporter 4 (MCT4) [9, 10].
Neurons take up this extracellular lactate via the MCT2, and
convert it back to pyruvate in a reaction catalyzed by lactate
dehydrogenase [8, 11]. Both neurons and astrocytes then use
pyruvate intracellularly to fuel oxidative metabolism. Physiolog-
ical studies over recent years have shown that neurons prefer
lactate as an bioenergetic substrate [11, 12], although both glu-
cose and lactate can strongly stimulate oxidative metabolism in
mature neurons [12, 13]. However, the metabolic fuel require-
ments of adult neural stem cells are not known.
In this report, we demonstrate that neural stem cells
derived from the mouse SVZ do not require glucose to sustain
oxygen consumption, unlike other cell types that have been
characterized in the adult brain. Instead, adult NSPCs are capa-
ble of using multiple fuel sources to maintain the high levels of
aerobic respiration necessary for cellular division. In particular,
fatty acids stimulate respiratory activity in these cells.
Beta-oxidation of fatty acids is performed by numerous
cell types, most notably cardiac myocytes and skeletal muscle
tissue [14]. Although mature cells within the adult brain
depend on carbohydrates such as glucose for energy produc-
tion, the fetal brain oxidizes primarily free fatty acids and
other related substrates derived from the mother’s milk [15,
16]. Metabolic dependence upon fatty acids appears to be
retained in adult neural stem cells. In this study, we per-
formed gain-of-function and loss-of-function studies to test
whether beta-oxidation contributes to energy production and
acts as a limiting factor in cellular proliferation. Here, we
report that adult neural stem cells in the SVZ rely upon fatty
acid oxidation to support aerobic respiration and proliferative
activity, although other fuels can also be oxidized.
MATERIALS AND METHODS
Immunohistochemistry
All experiments were performed as approved by the Univer-
sity of Washington Institutional Animal Care and Use Commit-
tee (IACUC) and United Kingdom Home Office Project Licence
Number 60/4386. Full details on experimental techniques are
available in Supporting Information Materials and Methods.
For immunohistochemical studies, wild-type adult C57BL/6
mice were killed and brain tissues were processed for cryo-
sectioning. Ten micrometer-thick slices were subjected to
0.01 M sodium citrate at 1008C for 10 minutes for antigen
retrieval. Sections were then rinsed with phosphate-buffered
saline (PBS) containing 0.1% Triton X-100 (PBST). Nonspecific
staining was blocked for 2 hours in PBS with 0.1% Triton X-
100 and 5% donkey serum (blocking solution). Sections were
incubated overnight at 48C with appropriate antibodies
diluted in blocking solution (details in Supporting Information
Table 1A). Sections were then rinsed with PBST. The appropri-
ate secondary antibodies were diluted by 1:250 in blocking
solution and placed on sections for 2 hours at room tempera-
ture (details in Supporting Information Table 1B). Sections
were rinsed and costained with Hoechst diluted to 1 lg/ml in
PBST. Fluorescence microscopy was performed using a Zeiss
Apoptome Microscope with attached camera and Axiovision
software.
Laser-Capture Microdissection
Cells within SVZ, OB, or cortex were microdissected using the
Zeiss PALM MicroBeam Laser-Capture Microdissection Micro-
scope. Cells were collected using the Ambion RNAqueous
MicroKit (Life Technologies, Carlsbad, CA, www.lifetechnolo-
gies.com) and stored at 2208C until ready for real-time poly-
merase chain reaction (PCR) analysis.
Real-Time PCR
Real-time PCR was used to quantify metabolic transcripts in
laser-captured tissue samples and serum-exposed dissociated
cells. The real-time PCR was based on the procedure
described previously [17], which quantifies fluorescence emit-
ted by dyes VICV
R
and FAMV
R
that are conjugated to probes
complementary to cDNA reverse-transcribed from mRNA tran-
scripts. The assay was performed on the StepOnePlus Real-
Time PCR System (Life Technologies, Carlsbad, CA). Samples
from each neuroanatomical area or serum-exposure timepoint
were each run in triplicate to quantify total copy number.
Each sample was normalized to the standard curve, using the
equation Value5 (CT2 Intercept)/Slope. These values were
normalized to B-actin. Total copy number of cDNA represent-
ing ACADL, CPT1, and MCT2 transcripts were compared
between neuroanatomical areas (in laser-captured samples) or
between serum-exposure timepoints (in cell cultures) using a
two-tailed t-test in Excel. Error bars are SEM.
Serum-Free Primary Culture of Mouse NSPCs
Adult NSPCs were isolated as described previously [18].
Briefly, wild-type C57BL/6 mice, 3 months of age, were trans-
cardially perfused with ice-cold saline. Brain tissue from the
SVZ was mechanically and enzymatically dissociated with
collagenase-DNase solution. To remove debris, myelin and red
blood cells, the cell suspension was mixed with a percoll solu-
tion and centrifuged. The isolated progenitor cells were grown
in proliferation media, consisting of Dulbecco’s modified
Eagle’s medium/F12 (Omega Scientific DM-25, Tarzana, CA,
www.omegascientific.com/) supplemented with 2 mM gluta-
mine, 1% N2 (Life Technologies, Carlsbad, CA), 50 lg/ml hepa-
rin (Sigma, St Louis, MO, www.sigmaaldrich.com), 20 ng/ml
epidermal growth factor (Peprotech, Rocky Hill, NJ, www.
peprotech.com), and 20 ng/ml fibroblast growth factor-2
(Peprotech, Rocky Hill, NJ). Cultures were passaged by
mechanical dissociation in the presence of trypsin-EDTA (Life
Technologies, Carlsbad, CA) and used for in vitro experimenta-
tion between passages 3 and 12. Cultures contain a relatively
homogenous, stable population of NSPCs (90% Nestin1; 80%
CD1331) [18]. In Supporting Information Figure 4, serum
exposure involved the use of normal DM25 medium supple-
mented with 10% fetal bovine serum (FBS). In Figure 6, neu-
ronal differentiation was achieved with 2% B27 supplement in
Neurobasal Medium. All in vitro experiments were performed
three times with separate biological replicates (each with
three technical replicates), except Seahorse Analyzer experi-
ments shown in Figure 3, which were performed three times
with separate biological replicates (each with five technical
replicates). Error bars are SEM.
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Extracellular Flux Analysis in Live Cells
For Figure 2, oxygen consumption rate (OCR) was measured
using a flow culture system adapted for extracellular flux anal-
ysis as described [19]. This system uses an ultrastable oxygen
sensor based on the detection of the decay of the phosphor-
escent emission from an oxygen-sensitive dye. For Figure 3,
OCR was measured using the Seahorse XF24 Extracellular Flux
Analyzer as described previously [20]. OCR measurements
were normalized to cell count per well and were averaged
across three independent experiments each with multiple rep-
licates. Results were statistically compared using two-tailed
t-tests in Excel and plotted in Prism.
Figure 1. Neural stem/progenitor cells (NSPCs) in adult mouse subventricular zone (SVZ) express enzymes required for fatty acid oxida-
tion. Cells expressing medium chain acyl CoA dehydrogenase (MCAD [A–E]) and trifunctional protein (TFP [F–J]) are observed in the SVZ
(A, F) and hippocampal dentate gyrus (DG) (B, G). A majority of cells expressing these enzymes in SVZ are observed to be colabeled
with SOX2, while none of the cells expressing fatty acid oxidation enzymes in DG are labeled with SOX2 (C, H). Higher-magnification
images of MCAD1 cells (D–E) and TFP1 cells (I–J) in SVZ (D, I) and DG (E, J) are shown. In SVZ, fewer than 5% of MCAD1 cells colabel
with KI67 and fewer than 5% of KI671 cells colabel with MCAD. Most MCAD1 cells (in red) do not colabel with glial fibrillary acidic
protein (GFAP1) astrocytes (K–O), S100B1 ependymal cells (P–T), or doublecortin (DCX1) neuroblasts (U–Y). All tissues were stained
with the pan-nuclear marker Hoechst (in blue) to demonstrate total cell number. Scale bar5 20 lm. Abbreviations: DCX, doublecortin;
DG, dentate gyrus; GFAP, glial fibrillary acidic protein; MCAD, medium chain acyl CoA dehydrogenase; SVZ, subventricular zone; TFP, tri-
functional protein.
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Assessment of Cellular Proliferation and Viability
To quantify the fractions of actively cycling cells in the popu-
lation, we used two methods: immunocytochemical labeling
of KI67 and fluorescence-activated cell sorting (FACS)-based
mitotic profiling. NSPCs were plated at a density of approxi-
mately 10,000 cells per well on coated glass coverslips for 24
hours in growth medium. Cells were then treated with 10 ll
of dPBS, 5 mM etomoxir, or 5 mM linoleic acid, for a final
concentration of 100 lM etomoxir and 100 lM linoleic acid.
Immunohistochemistry was performed as above. TUNEL1
apoptotic cells were quantified as directed using a TdT Rea-
gent Kit (Chemicon Temecula, CA, www.emdmillipore.com). All
cells were costained with Hoechst diluted to 1 lg/ml in PBS
containing 0.1% Triton X-100. Coverslips were mounted onto
glass slides using Citifluor antifade glycerol reagent. Fluores-
cence microscopy was performed using a Zeiss Axioskop with
attached camera and Axiovision software. Treatment groups
were compared using two-tailed t-tests in Excel.
To make additional measurements of cellular proliferation,
we performed FACS-based mitotic profiling. Cells were plated
at a density of 106 cells per plate and incubated at 378C for
24 hours in growth medium. Cells were then treated with
PBS, etomoxir at a final concentration of 70 lM or linoleic
acid at a final concentration of 50 lM. Twenty-four hours
after treatment, cells were labeled with 2 lg/ml Hoechst in
permeabilization solution for 1 hour, then subjected to
fluorescence-associated cell sorting using LSRII. Mitotic profile
analysis was performed using ModFit software. Ten thousand
readings were taken for each replicate. Treatment groups
were compared using two-tailed t-tests in Excel.
To quantify the fraction of viable cells using an alternative
method, we used the ViCell automated cell counter to measure
total number of cells and the number of dead cells labeled posi-
tively with Trypan Blue dye. Cells were plated at 500,000 per
plate and counted 48 hours later. Fractions of viable cells in each
treatment group were compared using two-tailed t-tests in Excel.
Figure 2. Neural stem cells do not require glucose to sustain aerobic respiration. Shown is a representative trace of cultured neural
stem/progenitor cells (NSPCs) in a flow culture system outfitted for continuous metabolic analysis. Cells were exposed to differing con-
centrations of glucose over 210 minutes. Undifferentiated NSPCs do not sustain changes in oxygen consumption rate when glucose con-
centration is decreased to 0 mM, then returned to 5 mM, then increased to 25 mM for extended periods of time (A), although
simultaneous measures of lactate production drop to zero within 25 minutes of glucose removal (B). Abbreviations: glc, glucose; KCN,
potassium cyanide; OCR, oxygen consumption rate.
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Figure 3. Fatty acid oxidation is a primary contributor to aerobic respiration in primary-cultured neural stem/progenitor cells (NSPCs). The oxy-
gen consumption rate (OCR [A, E]) and extracellular acidification rate (ECAR [B, F]) of primary-cultured NSPCs were assessed using the seahorse
analyzer. Baseline measurements were taken for cells in plain medium (2 glutamine – glucose, red circles), for cells in medium1 L-glutamine
(orange triangles), for cells in medium1 glucose (yellow squares), and for cells exposed to 10% fetal bovine serum for 48 hours before the experi-
ment (green diamonds). Cells were then treated with 100 lM linoleic acid, a polyunsaturated fatty acid. The concentration was then increased to
200 lM of linoleic acid. Cells were then treated with 2.0 lM FCCP, which induces maximal respiration, and 2.5 lM antimycin A, which completely
inhibits aerobic respiration. (B): Cells do not show significant changes in OCR upon treatment with 100 lM linoleic acid, but cells do significantly
increase OCR upon further addition of linoleic acid. (C): The fraction of maximal oxidative respiratory capacity that is used under basal conditions
and after linoleic acid treatment is shown. (D): In a separate experiment, cells were treated with 100 lM etomoxir, an inhibitor of CPT1, the rate-
limiting enzyme in fatty acid oxidation; the concentration was then increased to 200 lM etomoxir. (E): All cells show significant decreases in OCR
upon treatment with 100 lM etomoxir, except cells that had been exposed to serum. Cells in plain medium or in medium containing L-glutamine
maintain decreased OCR upon further addition of etomoxir, while cells with glucose show a partial recovery (E). (F): The fraction of total respira-
tory capacity attributed to nonmitochondrial respiration, fatty acid oxidation and other aerobic metabolism is shown. Measurements were taken
every 9 minutes; data from three experiments were averaged together. †, p< 0.05; *, p< 0.01. Abbreviations: FCCP, carbonyl cyanide-p-trifluoro-
methoxyphenylhydrazone; OCR, oxygen consumption rate.
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Figure 4. Inhibition of fatty acid oxidation decreases proliferation in cultured neural stem/progenitor cells (NSPCs), but does not affect
cellular survival. Sample photomicrographs of cells treated with phosphate-buffered saline (PBS) (A, D), 100 lM etomoxir (B, E), or 100
lM linoleic acid (C, F) are shown, stained with either KI67, an S-phase cell cycle marker (A–C), or TdT, a marker of apoptosis (D–F). Sep-
arate channels are shown to display Hoechst, a pan-nuclear marker (0), and TdT or KI67 (00). The fraction of KI671 proliferating cells
decreases after 24 hours treatment with etomoxir (p< 0.05, G) and does not change after 24 hours of treatment with linoleic acid
(p> 0.05, not significant, G). The fraction of TdT1 apoptotic cells does not change significantly in either treatment group (p> 0.05, not
significant, H). The total cell count after 48 hours is significantly decreased in the presence of etomoxir at 100 lM concentrations
(p< 0.01, I) while cell viability remains unaffected (p> 0.05, not significant, J). Proliferation was also assessed by FACS-based mitotic
profiling of primary-cultured NSPCs. In one experiment, cells were treated with vehicle control (PBS, K) or 70 lM etomoxir (L). The frac-
tion of cells in G2/M phase of the cell cycle decreased from control levels after 24 hours treatment with etomoxir (p< 0.05, M). In a
separate experiment, cells were treated with vehicle control (N) or 50 lM linoleic acid (O). The fraction of cells in G2/M phase of the
cell cycle increased upon treatment with linoleic acid (p< 0.05, P). Scale bar5 20 lm.
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Pharmacological Inhibition of Fatty Acid and Lactate
Transport In Vivo
Female C57B/6 mice between 5 and 7 weeks of age were
injected intraperitoneally with 40 mg/kg etomoxir (Sigma, St
Louis, MO) in PBS, 40 mg/kg alpha-cyano-4-hydroxycinnamate
(4-CIN (Sigma, St Louis, MO)) in 1% methanol-PBS, or with similar
volumes of PBS. Animals were injected once per day for 3 days
and killed on day 4, approximately 24 hours after the final injec-
tion. Perfusion and immunohistochemistry were performed as
described above. Fluorescence microscopy was performed using
a Zeiss Apoptome with attached camera and Axiovision software.
Cell counts were compared using two-tailed t-tests in Excel.
Lentiviral-Mediated Gene Delivery of PGC1a and GFP
In Vitro and In Vivo
To restore the relevant enzymatic machinery for fatty acid oxi-
dation in aged NSPCs, we targeted NSPCs within SVZ for
genetic modification by intracerebral injection of high-titer
lentivirus encoding either green fluorescent protein (GFP)
alone or peroxisome proliferator-activated receptor gamma
coactivator 1 alpha (PGC1a) tagged with GFP. Two groups of
mice, aged 21 months, were injected in SVZ with either a
control virus expressing GFP or a virus expressing PGC1a
tagged with GFP (n5 4 per group). Additional animals
injected in a different location were used as controls to assess
the extent of lentiviral infection and target gene expression.
Animals were caged socially and killed by transcardial perfu-
sion 2 months after surgery. Tissues were fixed, sectioned,
stained, and visualized as described above. Cell counts were
compared using two-tailed t-tests in Excel.
RESULTS
Expression of Fatty Acid Oxidation Enzymes in Adult
SVZ and Hippocampus
Brain energy metabolism has been shown to shift from beta-
oxidation of fatty acids to glucose-based metabolism during
weaning [15, 16]. As a result, oxidation of fatty acids and
ketone bodies in the central nervous system decreases drasti-
cally during maturation. We hypothesized that NSPCs however
maintain a metabolic phenotype similar to less-differentiated
cells in the fetal brain. To test this question, we assessed
whether enzymes required for fatty acid oxidation were pres-
ent in NSPCs located within neurogenic areas of the adult
brain.
Cells expressing medium chain acyl CoA dehydrogenase
(MCAD) and trifunctional protein (TFP) are observed in the
SVZ and hippocampal DG (Fig. 1). Positively labeled cells are
also observed in the hypothalamic nuclei (not shown), as has
been observed previously [21, 22]. Cells in hippocampal DG
that labeled positively for markers of fatty acid oxidation did
not colabel with SOX2, a marker of progenitor cells. The cells
expressing fatty acid oxidation enzymes in this area, therefore,
do not appear to be a progenitor population. However, a
majority of cells in SVZ containing these markers demonstrate
colabeling with SOX2, suggesting that SOX21 cells there are
capable of fatty acid oxidation. However, very few MCAD1
cells in SVZ colabel with KI67, an S-phase marker, suggesting
that actively proliferating cells are not undergoing fatty acid
oxidation. MCAD1 cells observed in SVZ also do not colabel
with GFAP1 astrocytes, S100B ependymal cells, or doublecor-
tin (DCX1) neuroblasts (Fig. 1). A negative control with no
primary antibody is shown in Supporting Information Figure 1
and individual channel images are shown in Supporting Infor-
mation Figures 2 and 3.
Because MCAD is a critical enzyme in the beta-oxidation
of medium-length fatty acids, all long-chain and medium-
chain fatty acids will be processed by this enzyme. Therefore,
if a cell undergoes fatty acid oxidation, it will contain this par-
ticular enzyme. Therefore, we have colabeled tissues with a
mouse monoclonal antibody against MCAD in combination
with polyclonal antibodies against GFAP, S100B, and DCX to
investigate the identity of cells capable of fatty acid oxidation.
Changes in Metabolic Gene Expression During Cellular
Maturation
Differentiation into a mature neuron or astrocyte may involve
modulating the metabolic machinery by upregulating gene
products necessary for cell-specific metabolic activity. Recent
studies have shown that differentiation of embryonic day 14
(E14) neural stem cells into astrocytes, by addition of FBS to
the culture medium, induces astrocyte-specific metabolic char-
acteristics such as glycogenolysis during the same timeframe
necessary to develop typical morphological and immunohisto-
chemical characteristics of astrocytes [23, 24]. We hypothe-
sized that differentiating cells in the adult brain may
recapitulate developmental processes by becoming less
dependent on beta-oxidation of fatty acids and becoming
more dependent upon carbohydrates and monocarboxylates.
To test whether metabolic machinery is remodeled in neu-
rogenic areas of the adult brain, we performed laser-capture
microdissection and real-time PCR to quantify metabolic tran-
scripts in NSPCs from adult mouse SVZ, adult-born neurons
from the OB, and embryonically born neurons from cortex
(Supporting Information Fig. 4A–4E). Cells taken from OB do
not have significantly lower levels of transcripts for the fatty
acid oxidation enzymes long-chain acyl CoA dehydrogenase
(ACADL) and Carnitine Palmitoyl Transferase I (CPT1), although
cortical cells do have significantly lower levels of these tran-
scripts compared with SVZ cells. Similar to cortical cells, cells
taken from OB demonstrate significantly higher levels of tran-
scripts for MCT2 compared with SVZ cells.
Next, we aimed to establish a timeline of metabolic gene
expression during in vitro differentiation of adult NSPCs over
24 hours of serum exposure (Supporting Information Fig. 4D–
4L). We observed no changes in the quantity of transcripts for
ACADL or CPT1 during this time period. However, we did
observe significant increases in MCT2 transcripts. Together,
these findings suggest that adult-born neurons and glia
acquire lactate transport machinery during differentiation but
do not lose expression of enzymes required for fatty acid oxi-
dation. This change in gene expression manifests early, as cells
are only starting to show morphological and immunohisto-
chemical signatures of differentiation.
Substrates Used by NSPCs to Support Aerobic
Respiration
Previous studies have shown that changes in glucose concen-
tration cause strong, sustainable changes in the OCR of both
neurons and astrocytes [12, 13]. Here, we tested the response
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of NSPCs to changes in glucose concentration using a flow
culture system to measure OCR and the extracellular acidifica-
tion rate (ECAR) caused by continuous lactate production (an
indirect measure of glycolytic activity). We observed that OCR
remains steady through changes in glucose concentration,
although lactate production drops to zero within 25 minutes
of glucose removal (Fig. 2). Upon addition of glucose, a slight
rise in OCR is observed, with the opposite effect observed
upon removal of glucose. However, OCR returns to baseline
levels shortly after any change in glucose concentration. These
data suggest that neural stem cells do metabolize glucose, but
are not dependent upon glucose to sustain aerobic
respiration.
As primary-cultured NSPCs do not require glucose to sus-
tain aerobic respiration, they must have alternative metabolic
fuel requirements than other cells within the adult brain. We
hypothesized that fatty acids are instead used by NSPCs as
substrates to power aerobic metabolism. To test this hypothe-
sis, we compared the responses of undifferentiated and
serum-differentiated NSPCs to the polyunsaturated fatty acid
linoleic acid and the drug etomoxir, which inhibits the rate-
limiting enzyme in fatty acid oxidation (CPT1). For these
experiments, OCR was measured in live cells in real time
using a Seahorse Analyzer. The addition of polyunsaturated
fatty acids increases OCR significantly, even in the presence of
alternative metabolic substrates such as L-glutamine or glu-
cose (Fig. 3A–3C). Pharmacological inhibition of fatty acid oxi-
dation significantly decreases OCR in all groups (Fig. 3D–3F);
however cells with access to glucose can recover OCR upon
increased concentrations of etomoxir (Fig. 3D–3E). Cells that
had been exposed to serum for 48 hours before experiments
demonstrate an abrogated response to etomoxir, only slightly
decreasing OCR in response to this inhibitor of fatty acid oxi-
dation (Fig. 3D–3F). However, these cells are still capable of
increasing respiratory rate in response to linoleic acid (Fig.
3A–3C).
Effects of Pharmacological Inhibition of Fatty Acid
Oxidation In Vitro
To test whether fatty acid oxidation plays a role in cellular
survival and proliferation, we treated primary-cultured mouse
NSPCs with 100 lM etomoxir, 100 lM linoleic acid, or a
vehicle control, then stained with either KI67, a cell cycle
marker, or TdT, a marker of apoptosis (Fig. 4A–4H). The frac-
tion of KI671 proliferating cells decreases with etomoxir
treatment, while the fraction of TdT1 apoptotic cells does
not change significantly in either treatment group. In a sepa-
rate assay, we found that doses of etomoxir approaching
100 lM decrease cell number significantly without affecting
cell viability (Fig. 4I, 4J). We then subjected cells to FACS-
based mitotic profiling as an additional measure of prolifera-
tive activity (Fig. 4K–4P). We again observed significant
decreases in the fraction of actively cycling cells upon eto-
moxir treatment. Since etomoxir decreases KI671 index, the
total cell count, and the fraction of cells in S1G2/M phase
of the cell cycle, without affecting the TdT1 or Trypan
Blue1 cell population, the function of this catabolic pathway
appears to be important for the proliferation of neural stem
cells. These data suggest that inhibition of fatty acid oxida-
tion blocks proliferation of NSPCs without affecting rates of
apoptosis.
Effects of Pharmacological Inhibition of Fatty Acid
Oxidation In Vivo
To test whether inhibition of fatty acid oxidation blocks pro-
liferation of NSPCs in vivo, female mice between 5 and 7
weeks of age were injected intraperitoneally on three consec-
utive days with 40 mg/kg etomoxir, 40 mg/kg 4-CIN, or simi-
lar volumes of saline. The fraction of KI671 cells and the
fraction of SOX21 cells were assessed immunohistochemi-
cally (Fig. 5). We observed a significant decline in KI671 cells
in the SVZ in etomoxir-treated animals but no significant
decline in KI671 cells in this area in 4-CIN-treated animals.
The SOX21 population in SVZ is unaffected in both treat-
ment groups. We observed no decline in KI671 cells in the
hippocampal dentate gyrus; indeed, 4-CIN treatment was
associated with a significant increase in mitotic index in this
area. SOX21 cells in DG are unaffected by treatment with
either etomoxir or 4-CIN. These data suggest that SVZ and
hippocampal DG have different responses to metabolic inhibi-
tors which might be predicted by enzyme expression patterns
observed in Figure 1.
Rescue of Neurogenic Activity in the Aged Brain by
Increasing Aerobic Metabolic Capacity
Few neurons are produced in the aged brain, and the major-
ity of neurogenic decline occurs by middle age. Aged NSPCs
exhibit decreases in both mitochondrial content and aerobic
respiratory activity [25]. We hypothesized that expanding the
aerobic capacity of the remaining population of NSPCs in the
aged brain may boost neurogenesis and rescue regenerative
activity. To do so, we performed lentiviral-mediated rescue of
a mitochondrial biogenesis factor within aged SVZ NSPCs. The
target gene, PGC1a, induces mitochondrial biogenesis, coordi-
nating an increase in mitochondrial number and metabolic
gene expression, which has been shown to rescue oxidative
respiration in cardiac myocytes [26, 27].
To test whether PGC1a affects metabolic gene expression
in NSPCs, we overexpressed PGC1a-GFP or GFP alone (as a
control) in cultured NSPCs from the aged mouse brain.
Lentiviral-mediated transduction increases PGC1a expression
and MCAD1 mitochondrial content (Fig. 6A–6K). Grown in
proliferation medium, cultures transduced with PGC1a have a
higher KI671 index compared with controls (Fig. 6L–6N). Sus-
tained in differentiation medium (2% B27 in Neurobasal
Medium), cultures transduced with PGC1a have no difference
in DCX1 index or viability (Fig. 6O–6R). These results indicate
that PGC1a increases respiratory capacity and proliferative
activity, but do not affect the propensity of cells to survive or
undergo neuronal differentiation.
We targeted NSPCs within SVZ for genetic modification
by intracerebral injection of high-titer lentivirus tagged with
GFP. Two groups of mice, aged 21 months, were injected
with either the control virus expressing GFP or the virus
expressing PGC1a tagged with GFP under the same constitu-
tive promoter. The animals were killed 2 months after sur-
gery. We observed similar numbers of GFP1 cells remaining
in the SVZ of control and experimental animals; however,
ectopic expression of PGC1a was associated with an
increased number of GFP1 cells in some areas of the OB,
specifically the mitral cell layer and the external plexiform
layer (Fig. 7A–7H). While GFP1 cells in the OB of control
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Figure 5. Inhibition of fatty acid oxidation decreases proliferation in subventricular zone (SVZ) but not hippocampal dentate gyrus.
Adult mice received three injections of saline (A, B), 40 mg/kg etomoxir (C, D) or 40 mg/kg alpha-cyano-4-hydroxycinnamate (4-CIN) (E,
F). The fraction of KI671 cells and the fraction of SOX21 cells was assessed within SVZ (A, C, E) and hippocampal dentate gyrus (DG)
(B, D, F). Etomoxir treatment is associated with a significant decrease in KI671 cells in SVZ (p< 0.05, G), while the effect of 4-CIN on
this population was not significant (p> 0.05, G). KI671 cell number in the hippocampal DG was unchanged upon etomoxir treatment
(p> 0.05, H), but significantly increased upon 4-CIN treatment (p< 0.05, I). The SOX21 progenitor cell population was unaffected in
both areas in both treatment groups (p> 0.05, not significant, J). Scale bar5 40 lm. Abbreviations: 4-CIN, alpha-cyano-4-hydroxycinna-
mate; DG, dentate gyrus; SVZ, subventricular zone.
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animals did not colabel with neuronal markers, PGC1a-
overexpressing GFP1 cells colabeled with DCX and tyrosine
hydroxylase (TH) (Fig. 7I–7L). These data suggest that
increased metabolic capacity can promote the regenerative
potential of aged NSPCs to a limited extent.
DISCUSSION
Molecular mechanisms shown to regulate the rate of
adult neurogenesis include both cell-intrinsic factors,
such as tumor suppressor proteins [28–30], and factors
within the microenvironment, such as growth factors
[31]. In addition, some behaviors affect neurogenic activ-
ity. For example, voluntary exercise has been shown to
increase cellular proliferation in the adult hippocampus
[2] while diets high in monounsaturated fatty acids
decrease the BrdU1 proliferative cell index in the adult
hippocampus [32]. Although molecular pathways within
the cell and factors within the microenvironment have
been proposed to regulate the rate of adult neurogenesis
[33], a blood-borne factor directly linking behavioral
activity with neurogenic activity has not been identified.
Metabolic fuel availability may provide such a link.
Manipulating the fuel availability of neural stem cells
may indeed uncover mechanisms by which organismal
behavior, energy consumption, and cellular activity are
coupled in the adult mammalian brain.
In this study, we identify the metabolic fuel requirements
of NSPCs and the underlying enzymatic machinery in these
Figure 6. Ectopic proliferator-activated receptor gamma coactivator 1 alpha (PGC1a) expression increases medium chain acyl CoA dehy-
drogenase (MCAD1) mitochondrial content and KI671 mitotic index in cultured neural stem/progenitor cells (NSPCs). NSPCs from the
young adult (A) and aged adult (B) mouse brain were labeled with MitoTracker Red; separate channels are shown to display this mito-
chondrial marker (0), and green fluorescent protein (GFP) (00). Fewer mitoRED1 mitochondria are observed in cultures from aged adult
brain than from young adult brain (p< 0.01), when normalized per cell (C) or per unit area (D). NSPC cultures derived from 18-month-
old mouse brain were transduced with lentivirus to express GFP alone (E) or PGC1a-GFP (F). Separate channels are shown to display
PGC1a expression (0), and the pan-nuclear marker Hoechst (00). A 150% increase in nuclear PGC1a expression, compared with control,
was observed by immunocytochemistry (p< 0.05, G–H). Cells expressing PGC1a demonstrate higher MCAD expression than control cells
(p< 0.01, I–K). Cultures transduced with PGC1a-GFP have a higher KI671 index under growth conditions (p< 0.05, L–N). The cultures
have no difference in doublecortin (DCX1) index (p> 0.05, O–Q) or trypan blue- viability (p> 0.05, R) after a 4-day differentiation pro-
tocol. Scale bar5 20 lm. Abbreviations: DAPI, 40,6-diamidino-2-phenylindole; DCX, doublecortin; GFP, green fluorescent protein; MCAD,
medium chain acyl CoA dehydrogenase; PGC1a, proliferator-activated receptor gamma coactivator 1 alpha.
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Figure 7. Ectopic proliferator-activated receptor gamma coactivator 1 alpha (PGC1a) expression increases subventricular zone (SVZ)-
based neurogenesis in aged mice. Injection of lentivirus into a target location with nonmigratory cells demonstrates the extent of infec-
tion in the mouse brain 2 months post-injection (A). The olfactory bulb (OB) in this same animal is observed to contain few green fluo-
rescent protein (GFP1) cells, as expected (B). The remainder of mice were injected into the target location containing proliferative cells
along the lateral ventricle. These animals have very few GFP1 cells in the SVZ when analyzed 2 months after inducing ectopic expres-
sion of GFP alone (C) or PGC1a1GFP (E). Most GFP1 cells are observed in the OB 2 months after infection with virus encoding GFP
alone (D) or PGC1a1GFP (F). The total number of GFP1 cells in SVZ was not significantly different between groups (p> 0.05, G). The
fraction of total cells expressing GFP was significantly higher in the PGC1a group compared with the control group in some areas of OB,
specifically in the mitral cell layer and the external plexiform layer (p< 0.05, H) but not in the granule cell layer or the glomerular layer
(p> 0.05, H). GFP1 cells in OB overexpressing PGC1a colabeled with doublecortin (DCX, I–J) and tyrosine hydroxylase (TH, K–L), but not
calretinin (CalR, K–L). Scale bar5 100 lm. Abbreviations: DCX, doublecortin; GFP, green fluorescent protein; OB, olfactory bulb; PGC1a,
proliferator-activated receptor gamma coactivator 1 alpha; SVZ, subventricular zone; TH, tyrosine hydroxylase.
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cells and we describe how both the enzymatic machinery and
the physiological response to catabolic substrates changes
during the process of differentiation. In addition, we tested
whether the availability of metabolic substrates, particularly
fatty acids, can limit proliferative activity in vivo using phar-
macological and genetic methods.
Fatty acids are present in the bloodstream of adult mam-
mals, commonly bound to serum albumin. The concentration
of free fatty acids in human blood has been estimated at 444
lM, or 74% of albumin concentration estimated at 600 lM
[34]. The total concentration of fatty acids in human serum
has been estimated at 3290 lg/ml, including saturated fats,
monounsaturated fatty acids and polyunsaturated fatty acids
[35]. A full 30% of these fatty acids (1009 lg/ml) in human
blood plasma are in the form of linoleic acid, which is present
in quantities approaching 3.6 mM. Linoleic acid is, therefore,
a readily available metabolic substrate.
Fatty acids can enter a cell directly or be produced within
the cell itself. Indeed fatty acids have been shown to be pro-
duced endogenously in adult NSPCs [36]. These fatty acids can
be used as raw materials to build cell membranes or be
metabolized into cannabinoids, eicosenoids, and other bioactive
agents. Alternatively, they can be used to produce energy
within the mitochondrion by a process called beta-oxidation. To
enter the mitochondrion, a fatty acid must be esterified to acyl
CoA by acyl CoA synthetase. Within the intermembrane space,
the fatty acyl-CoA is then converted to an acyl-carnitine by
CPT1 and is transported across the inner mitochondrial mem-
brane by carnitine translocase. Once inside the mitochondrial
matrix, the carnitine is coverted back into a fatty acyl-CoA. This
molecule is first oxidized by a chain-length-specific acyl CoA
dehydrogenase (i.e., MCAD, LCAD), in the process reducing FAD
to FADH2. The resulting molecule is hydrated, oxidized again,
and then cleaved into a fatty acyl-CoA and acetyl-CoA in a final
step called ketothiolysis. These three steps are performed by
the same enzyme, TFP. The acetyl-CoA molecule is used in
other bioenergetic pathways such as the Kreb’s Cycle, while the
remaining fatty acyl-CoA (now two carbons shorter than the
original molecule) restarts the four-step process of beta-
oxidation. Critically, beta-oxidation can be inhibited pharmaco-
logically with etomoxir, which blocks the activity of the rate-
limiting transport enzyme CPT1.
The various experiments performed in this study yield a
consistent image of the metabolic substrates preferred by
NSPCs and their newly differentiated progeny. SOX21 pro-
genitor cells in SVZ but not hippocampal DG express
enzymes required for fatty acid oxidation, and inhibition of
this pathway in vivo decreases proliferative activity within
SVZ but not DG. As expected, cellular differentiation, both in
vivo and in vitro, leads to increased expression of the MCT.
However, the same cells do not lose expression of fatty acid
oxidation enzymes. Correspondingly, serum-exposed NSPCs
retain responsiveness to linoleic acid but are unaffected by
inhibition of fatty acid oxidation. The differentiated cells
therefore seem able to metabolize either glucose or fatty
acids, depending on substrate availability, better than the
undifferentiated cells. Undifferentiated NSPCs rely greatly
upon fatty acid oxidation for their proliferative activity, since
etomoxir treatment leads to significant decreases in aerobic
respiratory activity, KI671 index, and FACS mitotic profile.
We observed significant increases after linoleic acid treat-
ment in FACS-based assays but not in KI671 labeling index.
This discrepancy may be due to the difference in a suspen-
sion assay versus a monolayer assay. A detergent effect of
the fatty acid could have caused mitotic cells loosely adher-
ent to the coverslip to be washed away during staining;
since all cells were spun down and collected for FACS-based
mitotic profiling, such an occurrence would not have led to
a loss of cells. The necessity of fatty acid oxidation for neu-
rogenic activity was borne out by further experiments in
vivo. The relative importance of fatty acids over lactate was
demonstrated in a pharmacological study using etomoxir and
4-CIN, respectively. The results in the SVZ were consistent
with other findings in this study, supporting the requirement
of fatty acid oxidation for proliferative activity. However, the
results in the hippocampus were intriguing. It appears that
inhibiting lactate metabolism with 4-CIN actually boosts stem
cell identity and activity in DG. Perhaps new neurons are
forced to remain in cell cycle when rendered unable to use
the preferred substrate of neurons. Further experiments are
needed to understand the metabolic fuel requirements of
NSPCs in DG.
The remaining population of stem-like cells in the aged
brain demonstrate decreased aerobic capacity. Specifically,
aged NSPCs have decreased mitochondrial mass and lower
baseline OCRs compared with young NSPCs [25]. In this
report, we show that expanding the aerobic capacity of the
remaining population of NSPCs in the aged brain, by ectopi-
cally expressing PGC1a within the SVZ, increases mitotic activ-
ity in vitro and boosts new neuron number in some areas of
the OB. PGC1a is a broad regulator of aerobic metabolism,
increasing mitochondrial content, mitochondrial DNA replica-
tion, and metabolic gene expression [26, 27, 37]. However,
this factor can have other effects on a cell, particularly on
neuronal gene expression. Interestingly, one recent study
demonstrated reduced parvalbumin (PV) expression and a
decreased number of PV interneurons in animals lacking
PGC1a [38] while another study demonstrated reduced TH
expression upon ectopic PGC1a expression in dopaminergic
neurons [39]. These studies suggest that PGC1a may play a
critical role in establishing cellular identity in the central nerv-
ous system. The mechanisms by which catabolic strategies
and mitochondrial remodeling link to neuronal physiological
function remains an active area of study.
As catabolic activity is a fundamental characteristic of a
cell, exquisitely optimized to meet energetic needs and con-
straints, the identification of metabolic substrates required by
the adult neural stem cell is imperative to understanding the
process of regeneration. It is possible that different cell types
rely upon different bioenergetic fuels. Different neuronal and
glial subtypes in the brain may have distinctive “batteries”
which confer cell-specific properties, like glycolytic fast-twitch
and fat-burning slow-twitch fibers in skeletal muscle tissue. In
addition, molecular sensors that coordinate catabolic and ana-
bolic activity within brain cells may contribute to sensing the
local availability of bioenergetic substrates and adjusting phys-
iological activity accordingly. Characterizing cell-specific meta-
bolic machinery may therefore inform on cellular identity and
physiological function.
In light of this study, an improved understanding of meta-
bolic limitations on cellular proliferation may aid strategies to
boost regenerative potential in the injured or aged central
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nervous system. However, further testing is needed before an
expansion of metabolic capacity can be considered as an
approach to counter age-related cognitive decline. In particular,
it is important to assess whether such interventions can
enhance cognition in animal models and whether any side
effects are observed from augmenting proliferation in the
endogenous neural stem/progenitor population.
CONCLUSIONS
Endogenous neural stem cells are excellent therapeutic tar-
gets, retaining the capacity to rebuild and repair tissue in the
adult brain by producing new neurons and astrocytes. A great
aim of regenerative medicine is to identify methods to sup-
port the self-renewal of this population in the aged or dis-
eased brain. Regulation of metabolic fuel availability could
prove a powerful tool in promoting or constraining regenera-
tion in the central nervous system.
Cell division is an energetically expensive task. While
mature cells in the adult brain have been shown to rely upon
carbohydrates such as glucose, the bio-energetic substrates
utilised by neural stem cells have heretofore been uncharac-
terized. In this study, we show that neural stem cells in the
adult brain rely largely on fatty acids to fuel energy produc-
tion. Using a combination of techniques, we demonstrate that
fatty acid oxidation is required for neural stem cells to sustain
aerobic respiration and proliferative activity. Our results have
important implications for the study of stem cell biology, by
introducing the role of bio-energetic capacity as a limiting fac-
tor in neurogenic activity and as a defining factor in cellular
identity.
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